Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock

Equities

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E. 18:00:00 2024-06-16 EDT 5-day change 1st Jan Change
35.25 CNY +0.03% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -4.21% +4.75%

Financials

Sales 2024 * 9.05B 1.25B 1.71B Sales 2025 * 9.96B 1.37B 1.89B Capitalization 23.79B 3.28B 4.51B
Net income 2024 * 1.17B 162M 222M Net income 2025 * 1.4B 193M 265M EV / Sales 2024 * 2.63 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.39 x
P/E ratio 2024 *
23.1 x
P/E ratio 2025 *
19.4 x
Employees 4,619
Yield 2024 *
-
Yield 2025 *
-
Free-Float 31.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.65%
1 week-4.24%
Current month+0.20%
1 month-3.35%
3 months+18.02%
6 months+2.65%
Current year+4.73%
More quotes
1 week
34.60
Extreme 34.6
37.37
1 month
34.51
Extreme 34.51
38.04
Current year
23.40
Extreme 23.4
38.04
1 year
23.40
Extreme 23.4
46.95
3 years
17.98
Extreme 17.98
56.26
5 years
12.05
Extreme 12.05
56.26
10 years
11.80
Extreme 11.8
56.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 22-08-21
Director of Finance/CFO 46 23-07-20
Chief Tech/Sci/R&D Officer 54 12-11-30
Members of the board TitleAgeSince
Director/Board Member 63 11-27
Chief Tech/Sci/R&D Officer 54 12-11-30
Director/Board Member 53 21-12-09
More insiders
Date Price Change Volume
24-06-16 35.25 +0.03% 4 840 642
24-06-14 35.24 -0.65% 7,161,897
24-06-13 35.47 -3.25% 9,885,652
24-06-12 36.66 -0.81% 3,947,060
24-06-11 36.96 +0.43% 4,959,511

End-of-day quote Shanghai S.E., June 13, 2024

More quotes
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
35.24 CNY
Average target price
45.8 CNY
Spread / Average Target
+29.97%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600329 Stock